Project Grant R21DA042960

This Project Grant award of $1,951,307 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Medical University of South Carolina (MUSC). The funding will support a longitudinal cohort study investigating the use patterns and trajectories of dual users of combustible and electronic cigarettes, to better understand how these patterns relate to smoking cessation. The study, led by researchers at MUSC and the University...

This federal Project Grant award of $2,153,960.00, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to evaluate the effectiveness of providing e-cigarettes alone versus e-cigarettes plus a behavioral support intervention ("SWITCH IT") to boost switching from combustible cigarettes among chronic smokers with mental illness. The award, with a start date of June 1, 2024 and an ultimate completion date of March 31,...

This $687,995.00 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program will support a randomized clinical trial to investigate the efficacy of varenicline, an FDA-approved smoking cessation medication, for helping adults who use e-cigarettes exclusively to quit vaping. The study will be conducted by Yale University and aims to compare quit rates between participants receiving varenicline versus placebo over a 12-week...

This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) provides $1,615,000 to The Regents of the University of California, San Francisco (UCSF) to investigate the cardiovascular effects of dual use of cigarettes and electronic cigarettes (e-cigarettes). The research project aims to: 1) Understand the cardiovascular health effects of dual use of a...

This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,973,823 to The Medical University of South Carolina (MUSC) to evaluate a tobacco harm reduction strategy among clients enrolled in substance use disorder (SUD) treatment. The study will conduct a hybrid type 1 effectiveness-implementation randomized controlled trial to assess the impact of switching to electronic nicotine delivery...

The National Cancer Institute (NCI) awarded a $310,319 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the University of Louisville to conduct research on a motivation-based adolescent vaping typology to inform e-cigarette cessation interventions. The 3-year project aims to fill critical knowledge gaps and develop tailored cognitive behavioral e-cigarette cessation treatment protocols for adolescent e-cigarette users based on their motivations for use. The...

This is a Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research federal grant program (CFDA 93.393). The $619,175 award will support a clinical trial to evaluate the effectiveness of an e-cigarette switching approach as a harm reduction intervention for oncology outpatients who smoke but refuse traditional tobacco treatment. The trial, conducted by the Medical University of South Carolina, will directly compare rates of switching to...

This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), will fund a study to evaluate a remote, young adult lay-counselor delivered behavioral and digital intervention called "QuitVaping" to promote nicotine vaping cessation and prevent escalation of tobacco use among youth. The $1,698,536 award to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), will...

The National Cancer Institute (NCI) awarded a $257,415 project grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to The Research Foundation for the State University of New York (RF SUNY) to develop and pilot test an AI-enhanced, smartphone app-based intervention for adolescent e-cigarette cessation. The project aims to create a scalable, personalized intervention that can be delivered through schools, clinics, and community settings to help address the growing public...

The National Cancer Institute (NCI) awarded a 5-year, $692,872 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to The Regents of the University of California, San Francisco (UCSF) to develop and evaluate a scalable social media-based vaping cessation program for adolescents aged 13-21. The program, called "Quit the Hit Toolkit" (QTHT), will be adapted for implementation by youth-serving organizations. It will be evaluated in a randomized controlled...